Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2010-10-11

FDA Approved: TIAGABINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for tiagabine hydrochloride, resulting in updated labeling for the product marketed by Teva Pharmaceuticals USA, Inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tiagabine hydrochloride (tiagabine hydrochloride)

Snippet

SUPPL AP for TIAGABINE HYDROCHLORIDE (TIAGABINE HYDROCHLORIDE)